7291 - 7300 of 8620 Results
Title
Year
-
RESTRICTEDTitle: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 42End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013Citation Count: 4
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
-
RESTRICTEDTitle: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 229End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007Best OA location URL: http://infoscience.epfl.ch/record/205418Citation Count: 35
-
OPENTitle: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49258-1Best OA location URL: https://doi.org/10.1038/s41467-024-49258-1Citation Count: 16
-
OPENTitle: 0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s StudyJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0908Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468111/zsad077.0908.pdfCitation Count: 0
-
OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 43
-
RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 14
-
OPENTitle: Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse modelJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-025-02048-2Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-025-02048-2Citation Count: 0
-
OPENTitle: Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-73854-yBest OA location URL: https://www.nature.com/articles/s41598-020-73854-y.pdfCitation Count: 8
- Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes2020OPENTitle: Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2868End Page: 2871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa287Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2868/34032411/awaa287.pdfCitation Count: 10